amiodarone has been researched along with Obesity in 11 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although oral amiodarone (AMD) has been used for the management of atrial fibrillation (AF), serious complications such as interstitial pneumonia (IP) occur very occasionally." | 7.83 | Obesity Is Associated With the Development of Interstitial Pneumonia Under Long-Term Administration of Amiodarone in Refractory Atrial Fibrillation Patients. ( Fujino, T; Fukunaga, S; Ikeda, T; Kinoshita, T; Kitahara, K; Kobayashi, K; Koike, H; Koike, M; Sato, H; Shinohara, M; Suzuki, T; Yuzawa, H, 2016) |
| "To evaluate the influence of obesity on pharmacokinetics of amiodarone (AMD) using Non-Linear Mixed Effects Modelling (NONMEM) in Japanese patients treated with oral therapy." | 7.75 | Effect of obesity on serum amiodarone concentration in Japanese patients: population pharmacokinetic investigation by multiple trough screen analysis. ( Araki, R; Fukuchi, H; Hayano, M; Komiya, N; Nakashima, M; Sasaki, H; Yano, K; Yukawa, E, 2009) |
| "Obesity is associated with an increased risk of development of chronic heart failure, but recent epidemiological studies indicate that a higher body mass index (BMI) is associated with a better survival rate." | 5.34 | [Combined therapy with weight loss and amiodarone improved cardiac function in a patient with idiopathic dilated cardiomyopathy complicated with severe obesity: a case report]. ( Kawano, S; Kozai, T; Tanaka, H; Urabe, Y, 2007) |
| "Although oral amiodarone (AMD) has been used for the management of atrial fibrillation (AF), serious complications such as interstitial pneumonia (IP) occur very occasionally." | 3.83 | Obesity Is Associated With the Development of Interstitial Pneumonia Under Long-Term Administration of Amiodarone in Refractory Atrial Fibrillation Patients. ( Fujino, T; Fukunaga, S; Ikeda, T; Kinoshita, T; Kitahara, K; Kobayashi, K; Koike, H; Koike, M; Sato, H; Shinohara, M; Suzuki, T; Yuzawa, H, 2016) |
| "Amiodarone has a high iodine content that can induce persistent iodine excess and may prevent radioiodine (RI) treatment." | 1.35 | Plasma exchanges overcome persistent iodine overload to enable 131I ablation of differentiated thyroid carcinoma. ( Dib-Deperrest, A; Hindie, E; Houzé, P; Moretti, JL; Parquet, N; Toubert, ME, 2008) |
| "Obesity is associated with an increased risk of development of chronic heart failure, but recent epidemiological studies indicate that a higher body mass index (BMI) is associated with a better survival rate." | 1.34 | [Combined therapy with weight loss and amiodarone improved cardiac function in a patient with idiopathic dilated cardiomyopathy complicated with severe obesity: a case report]. ( Kawano, S; Kozai, T; Tanaka, H; Urabe, Y, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Young, ML | 1 |
| Exelbert, EJ | 1 |
| Roth, T | 1 |
| Cohen, L | 1 |
| Cogan, J | 1 |
| Abdussalam, A | 1 |
| Al-Agili, M | 1 |
| Al Nebaihi, HM | 1 |
| Mayo, PR | 1 |
| Gabr, RQ | 1 |
| Brocks, DR | 1 |
| Simşek, H | 1 |
| Doğan, A | 1 |
| Sahin, M | 1 |
| Gümrükçüoğlu, HA | 1 |
| Koike, H | 1 |
| Fujino, T | 1 |
| Koike, M | 1 |
| Shinohara, M | 1 |
| Kitahara, K | 1 |
| Kinoshita, T | 1 |
| Yuzawa, H | 1 |
| Suzuki, T | 1 |
| Sato, H | 1 |
| Fukunaga, S | 1 |
| Kobayashi, K | 1 |
| Ikeda, T | 1 |
| Fukuchi, H | 1 |
| Nakashima, M | 1 |
| Araki, R | 1 |
| Komiya, N | 1 |
| Hayano, M | 1 |
| Yano, K | 1 |
| Sasaki, H | 1 |
| Yukawa, E | 1 |
| Menzorov, MV | 1 |
| Shutov, AM | 1 |
| Serov, VA | 1 |
| Schamroth, CL | 1 |
| Tanaka, H | 1 |
| Kawano, S | 1 |
| Kozai, T | 1 |
| Urabe, Y | 1 |
| Toubert, ME | 1 |
| Dib-Deperrest, A | 1 |
| Houzé, P | 1 |
| Parquet, N | 1 |
| Hindie, E | 1 |
| Moretti, JL | 1 |
| Wartofsky, L | 1 |
| Burman, KD | 1 |
| Linquette, M | 1 |
| Wemeau, JL | 1 |
| Cappoen, JP | 1 |
| Folliot, JP | 1 |
1 review available for amiodarone and Obesity
| Article | Year |
|---|---|
Alterations in thyroid function in patients with systemic illness: the "euthyroid sick syndrome".
Topics: Adult; Age Factors; Aged; Amiodarone; Animals; Anorexia Nervosa; Contrast Media; Diabetes Mellitus; | 1982 |
10 other studies available for amiodarone and Obesity
| Article | Year |
|---|---|
External Cardioversion-Defibrillation with Pushing Down on the Chest Wall to Increase the Success Rate in Obese Patients.
Topics: Adolescent; Aged; Amiodarone; Atrial Fibrillation; Electric Countershock; Female; Humans; Male; Midd | 2020 |
Dietary-Induced Obesity and Changes in the Biodistribution and Metabolism of Amiodarone in the Rat.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cytochrome P450 Family 2; Diet, Carbohydrate Loading; D | 2018 |
[A case of idiopathic ventricular tachycardia in a 14-year-old obese patient due to golden berry fruit extract pills for weight loss].
Topics: Administration, Oral; Adolescent; Amiodarone; Anti-Arrhythmia Agents; Diagnosis, Differential; Elect | 2013 |
Obesity Is Associated With the Development of Interstitial Pneumonia Under Long-Term Administration of Amiodarone in Refractory Atrial Fibrillation Patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillati | 2016 |
Effect of obesity on serum amiodarone concentration in Japanese patients: population pharmacokinetic investigation by multiple trough screen analysis.
Topics: Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agent | 2009 |
[Total body water and recurrent atrial fibrillation].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Body Mass Index; Body Water; Female; Humans | 2011 |
The perils of pharmacological treatment for obesity: a case of sibutramine-associated cardiomyopathy and malignant arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Appetite Depressants; Cardiomyopathy, Hypertrophic; Cyclobutanes | 2012 |
[Combined therapy with weight loss and amiodarone improved cardiac function in a patient with idiopathic dilated cardiomyopathy complicated with severe obesity: a case report].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Body Mass Index; Cardiomyopathy, Dilated; Diet, Reducing; | 2007 |
Plasma exchanges overcome persistent iodine overload to enable 131I ablation of differentiated thyroid carcinoma.
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Iodine; Iodine Radioisotopes; Lymphatic Metastasis; Male | 2008 |
[Mechanisms of T4 hyperthyroidism].
Topics: Aged; Amiodarone; Fasting; Female; Humans; Hyperthyroidism; Obesity; Thyroxine; Triiodothyronine | 1980 |